Rosen Law Firm Announces Investigation of ShangPharma Corporation in Connection with Going Private Transaction – SHP

Rosen Law Firm Announces Investigation of ShangPharma Corporation in Connection with Going Private Transaction – SHP

NEW YORK--(BUSINESS WIRE)-- The Rosen Law Firm announces that it is investigating potential securities fraud claims against ShangPharma Corporation (NYSE: SHP  ) pertaining to allegations that ShangPharma issued a misleading and inadequate proxy statement for its going private transaction.

If you would like to join the action please email or call Phillip Kim or Kevin Chan, toll-free, at 866-767-3653; or email at pkim@rosenlegal.com or kchan@rosenlegal.com. There is no cost or obligation to you.

Under the terms of the transaction, proposed by ShangPharma’s Chairman and Chief Executive Officer, Mr. Michael Xin Hui, and Chinese private equity firm TPG Star Charisma limited, shareholders will receive $9.00 for each American Depository Share (“ADS”) or $0.50 for each common share of ShangPharma they own. The investigation relates to whether ShangPharma’s Board violated Section 14 of the Securities Exchange Act of 1934 in issuing its proxy statement on January 31, 2013 for approval of the going private proposal.

If you own ShangPharma ADS and wish to obtain additional information, you may contact Phillip Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.



Phillip Kim, Esq.
Laurence Rosen, Esq.
The Rosen Law Firm P.A.
275 Madison Avenue 34th Floor
New York, New York 10016
Tel: (212) 686-1060
Weekends Tel: (917) 562-8616
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
pkim@rosenlegal.com
lrosen@rosenlegal.com
www.rosenlegal.com

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2231918, ~/Articles/ArticleHandler.aspx, 12/20/2014 8:08:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...